How have DGNOF shares performed in 2024?

DIAGNOS's stock was trading at $0.3050 at the beginning of 2024. Since then, DGNOF stock has decreased by 27.6% and is now trading at $0.2210. View the best growth stocks for 2024 here .

How were DIAGNOS's earnings last quarter?

DIAGNOS Inc. (OTCMKTS:DGNOF) announced its quarterly earnings data on Wednesday, February, 28th. The company reported ($0.01) EPS for the quarter. The company earned $0.04 million during the quarter.

How do I buy shares of DIAGNOS?

Shares of DGNOF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

OTCMKTS:DGNOF

DIAGNOS (DGNOF) Stock Price, News & Analysis

→ Biden’s $374B Giveaway Into This Sector (From DTI) (Ad)

Free DGNOF Stock Alerts

$0.22

0.00 (-0.63%)

(As of 04/18/2024 ET)

Compare

Today's Range: $0.22
▼
$0.22
50-Day Range: $0.18
▼
$0.25
52-Week Range: $0.18
▼
$0.43

Volume: 10,000 shs
Average Volume: 23,389 shs
Market Capitalization: $16.94 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis Chart Earnings Headlines Short Interest

Get DIAGNOS alerts:

Ad DTI

Biden’s $374B Giveaway Into This Sector

Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here

Click here for the full story

About DIAGNOS Stock (OTCMKTS:DGNOF)

DIAGNOS Inc. provides software-based services primarily in Canada, the United States, Colombia, Spain, Mexico, Saudi Arabia, and Costa Rica. The company offers healthcare services through Computer Assisted Retina Analysis, a web-based software tool that assists healthcare professionals for the detection of diabetic retinopathy; and allows eye care specialist to visualize both normal retinal landmarks and pathological changes. It also provides various consulting services in the fields of data analysis and artificial intelligence. DIAGNOS Inc. was founded in 1998 and is headquartered in Brossard, Canada.

DGNOF Stock Price History

30 days | 90 days | 365 days | Advanced Chart

DGNOF Stock News Headlines

April 16, 2024 | globenewswire.com

DIAGNOS to expedite application for Medical Device License to Health Canada and US FDA related to its 4 new analysis modules, and is planning ISO 27001 certification

April 9, 2024 | globenewswire.com

DIAGNOS Inc. to Present at the AI & Technology Hybrid Investor Conference April 11th

April 18, 2024 | DTI (Ad)

Biden’s $374B Giveaway Into This Sector

Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here

April 3, 2024 | globenewswire.com

DIAGNOS Announces Grant of Stock Options

April 2, 2024 | globenewswire.com

DIAGNOS Welcomes Dr. Philippe Couillard to its Board of Directors

March 22, 2024 | globenewswire.com

DIAGNOS Announces Closing of Second and Final Tranche of Private Placement

March 4, 2024 | globenewswire.com

DIAGNOS Announces Grant of Stock Options

February 29, 2024 | globenewswire.com

DIAGNOS Welcomes Mr. Michael Braeuel to its Board of Directors

April 18, 2024 | DTI (Ad)

Biden’s $374B Giveaway Into This Sector

Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here

February 27, 2024 | globenewswire.com

DIAGNOS Announces Closing of First Tranche of Private Placement

February 23, 2024 | globenewswire.com

Diagnos Announces Variation in One Insider Ownership of Common Shares

February 21, 2024 | globenewswire.com

DIAGNOS recognized as a Top TSX Venture Exchange Company

December 8, 2023 | nytimes.com

Best of 2023

See More Headlines

Receive DGNOF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for DIAGNOS and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 2/28/2024
Today: 4/18/2024
Fiscal Year End: 3/31/2025

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: OTCMKTS
Sector: Business Services
Industry: Private households
Sub-Industry: N/A
Current Symbol: OTCMKTS:DGNOF
CUSIP: N/A
CIK: N/A
Web: www.diagnos.ca
Phone: (450) 678-8882
Fax: N/A
Employees: N/A
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): ($0.04)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-1,880,000.00
Net Margins: -1,553.79%
Pretax Margin: -1,032.49%
Return on Equity: N/A
Return on Assets: -297.10%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 0.79
Quick Ratio: 0.79

Sales & Book Value

Annual Sales: $370,000.00
Price / Sales: 45.77
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: ($0.02) per share
Price / Book: -11.05

Miscellaneous

Outstanding Shares: 76,650,000
Free Float: N/A
Market Cap: $16.94 million
Optionable: Not Optionable
Beta: 0.20

These 7 Stocks Will Be Magnificent in 2024

With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.

Get This Free Report

Key Executives

Mr. Andre Larente
CEO, President & Executive Chairman
Mr. Marc-André Massue
VP of Finance, CFO & Secretary
Mr. Yves-Stéphane Couture
Chief Operating Officer
Mr. Martin Beland
Director of Marketing

Key Competitors

View All Competitors

DGNOF Stock Analysis - Frequently Asked Questions

How have DGNOF shares performed in 2024?: DIAGNOS's stock was trading at $0.3050 at the beginning of 2024. Since then, DGNOF stock has decreased by 27.6% and is now trading at $0.2210.
View the best growth stocks for 2024 here.
How were DIAGNOS's earnings last quarter?: DIAGNOS Inc. (OTCMKTS:DGNOF) announced its quarterly earnings data on Wednesday, February, 28th. The company reported ($0.01) EPS for the quarter. The company earned $0.04 million during the quarter.
How do I buy shares of DIAGNOS?: Shares of DGNOF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:DGNOF) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

DIAGNOS (DGNOF) Stock Price, News & Analysis

About DIAGNOS Stock (OTCMKTS:DGNOF)

DGNOF Stock Price History

DGNOF Stock News Headlines

Company Calendar

Industry, Sector and Symbol

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

DGNOF Stock Analysis - Frequently Asked Questions

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info